412 related articles for article (PubMed ID: 17719296)
21. Anti-platelet effects of 100 mg alternate day oral aspirin: a randomized, double-blind, placebo-controlled trial of regular and enteric coated formulations in men and women.
Ridker PM; Hennekens CH; Tofler GH; Lipinska I; Buring JE
J Cardiovasc Risk; 1996 Apr; 3(2):209-12. PubMed ID: 8836865
[TBL] [Abstract][Full Text] [Related]
22. Clopidogrel loading dose regimens: kinetic profile of pharmacodynamic response in healthy subjects.
Savcic M; Hauert J; Bachmann F; Wyld PJ; Geudelin B; Cariou R
Semin Thromb Hemost; 1999; 25 Suppl 2():15-9. PubMed ID: 10440417
[TBL] [Abstract][Full Text] [Related]
23. Randomized trial comparing 600- with 300-mg loading dose of clopidogrel in patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: results of the Platelet Responsiveness to Aspirin and Clopidogrel and Troponin Increment after Coronary intervention in Acute coronary Lesions (PRACTICAL) Trial.
Yong G; Rankin J; Ferguson L; Thom J; French J; Brieger D; Chew DP; Dick R; Eccleston D; Hockings B; Walters D; Whelan A; Eikelboom JW
Am Heart J; 2009 Jan; 157(1):60.e1-9. PubMed ID: 19081397
[TBL] [Abstract][Full Text] [Related]
24. Comparison of increased aspirin dose versus combined aspirin plus clopidogrel therapy in patients with diabetes mellitus and coronary heart disease and impaired antiplatelet response to low-dose aspirin.
Duzenli MA; Ozdemir K; Aygul N; Soylu A; Tokac M
Am J Cardiol; 2008 Aug; 102(4):396-400. PubMed ID: 18678294
[TBL] [Abstract][Full Text] [Related]
25. Clopidogrel did not inhibit platelet function early after coronary bypass surgery: A prospective randomized trial.
Lim E; Cornelissen J; Routledge T; Kirtland S; Charman SC; Bellm S; Munday H; Khan O; Masood I; Large S
J Thorac Cardiovasc Surg; 2004 Sep; 128(3):432-5. PubMed ID: 15354104
[TBL] [Abstract][Full Text] [Related]
26. Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel: results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial.
von Beckerath N; Taubert D; Pogatsa-Murray G; Schömig E; Kastrati A; Schömig A
Circulation; 2005 Nov; 112(19):2946-50. PubMed ID: 16260639
[TBL] [Abstract][Full Text] [Related]
27. Dual antiplatelet drug resistance in patients with acute coronary syndrome.
Guha S; Sardar P; Guha P; Roy S; Mookerjee S; Chakrabarti P; Deb PK; Chaudhuri U; Deb S; Karmakar R; Dasgupta AK; Lahiri P
Indian Heart J; 2009; 61(1):68-73. PubMed ID: 19729693
[TBL] [Abstract][Full Text] [Related]
28. Aprotinin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery: a double-blind, placebo-controlled, randomized clinical trial.
van der Linden J; Lindvall G; Sartipy U
Circulation; 2005 Aug; 112(9 Suppl):I276-80. PubMed ID: 16159831
[TBL] [Abstract][Full Text] [Related]
29. Variable platelet responsiveness to aspirin and clopidogrel: role of platelet function and genetic polymorphism testing.
Azam SM; Jozic J
Transl Res; 2009 Dec; 154(6):309-13. PubMed ID: 19931197
[TBL] [Abstract][Full Text] [Related]
30. Potent low dose platelet inhibitory effects of clopidogrel and aspirin on coronary thrombus formation in an animal model of acute unstable angina.
Bierbach B; Horstick G; Berg O; Heimann A; Münzel T; Vahl CF; Kempski O; Darius H
Thromb Haemost; 2006 Feb; 95(2):354-61. PubMed ID: 16502561
[TBL] [Abstract][Full Text] [Related]
31. Dose-dependent inhibition of human platelet aggregation by prasugrel and its interaction with aspirin in healthy subjects.
Jakubowski JA; Payne CD; Weerakkody GJ; Brandt JT; Farid NA; Li YG; Naganuma H; Lachno DR; Winters KJ
J Cardiovasc Pharmacol; 2007 Mar; 49(3):167-73. PubMed ID: 17414229
[TBL] [Abstract][Full Text] [Related]
32. Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial.
Wiviott SD; Trenk D; Frelinger AL; O'Donoghue M; Neumann FJ; Michelson AD; Angiolillo DJ; Hod H; Montalescot G; Miller DL; Jakubowski JA; Cairns R; Murphy SA; McCabe CH; Antman EM; Braunwald E;
Circulation; 2007 Dec; 116(25):2923-32. PubMed ID: 18056526
[TBL] [Abstract][Full Text] [Related]
33. Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin.
Husted S; Emanuelsson H; Heptinstall S; Sandset PM; Wickens M; Peters G
Eur Heart J; 2006 May; 27(9):1038-47. PubMed ID: 16476694
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
[TBL] [Abstract][Full Text] [Related]
35. Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease.
Wallentin L; Varenhorst C; James S; Erlinge D; Braun OO; Jakubowski JA; Sugidachi A; Winters KJ; Siegbahn A
Eur Heart J; 2008 Jan; 29(1):21-30. PubMed ID: 18055486
[TBL] [Abstract][Full Text] [Related]
36. Recovery of platelet function after discontinuation of prasugrel or clopidogrel maintenance dosing in aspirin-treated patients with stable coronary disease: the recovery trial.
Price MJ; Walder JS; Baker BA; Heiselman DE; Jakubowski JA; Logan DK; Winters KJ; Li W; Angiolillo DJ
J Am Coll Cardiol; 2012 Jun; 59(25):2338-43. PubMed ID: 22698488
[TBL] [Abstract][Full Text] [Related]
37. The effects of laropiprant on the antiplatelet activity of co-administered clopidogrel and aspirin.
De Kam PJ; Luo WL; Wenning L; Ratcliffe L; Sisk CM; Royalty J; Radziszewski W; Wagner JA; Lai E
Platelets; 2014; 25(7):480-7. PubMed ID: 24206527
[TBL] [Abstract][Full Text] [Related]
38. Effects of aspirin and clopidogrel in healthy men measured by platelet aggregation and PFA-100.
Madsen EH; Schmidt EB; Maurer-Spurej E; Kristensen SR
Platelets; 2008 Aug; 19(5):335-41. PubMed ID: 18791939
[TBL] [Abstract][Full Text] [Related]
39. Clopidogrel and drug metabolism: absence of effect on hepatic enzymes in healthy volunteers.
Pierce CH; Houle JM; Dickinson JP; Kindermans M; Serre-Lacroix E; Kieffer G; Necciari J
Semin Thromb Hemost; 1999; 25 Suppl 2():35-9. PubMed ID: 10440421
[TBL] [Abstract][Full Text] [Related]
40. A double-blind placebo-controlled investigation of the psychomotor profile of clopidogrel in healthy volunteers.
Adam JK; Rmaih WN
J Cardiovasc Pharmacol; 2008 Dec; 52(6):507-9. PubMed ID: 19034035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
